Manuscripts
Showing 1551 manuscripts.
Clinical trials of combination therapies for HIV infection. Rationale for development of multidrug therapy
Citation
Daniel F. Hoth. Clinical trials of combination therapies for HIV infection. Rationale for development of multidrug therapy. Journal of Acquired Immune Deficiency Syndromes. 1990. 3: S95-6.Year
1990
Journal
Journal of Acquired Immune Deficiency Syndromes
Radiologic distinction of pyogenic pulmonary infection from Pneumocystis carinii pneumonia in AIDS patients
Citation
J. Amorosa, Ronald G. Nahass, John L. Nosher, David J. Gocke. Radiologic distinction of pyogenic pulmonary infection from Pneumocystis carinii pneumonia in AIDS patients. Radiology. 1990. 175: 721-4.Year
1990
Journal
Radiology
Amphotericin B: delivery systems
Citation
J. Brajtburg, William G. Powderly, George S. Kobayashi, Gerald Medoff. Amphotericin B: delivery systems. Antimicrobial Agents and Chemotherapy. 1990. 34: 381-4.Year
1990
Journal
Antimicrobial Agents and Chemotherapy
Myristoylation-dependent replication and assembly of human immunodeficiency virus 1
Citation
Martin Bryant, Lee Ratner. Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proceedings of the National Academy of Sciences of the United States of America. 1990. 87: 523-7.Year
1990
Journal
Proceedings of the National Academy of Sciences of the United States of America
Neuropsychometric performance of asymptomatic HIV-infected subjects
Citation
David B. Clifford, Robert G. Jacoby, J. Philip Miller, Warren R. Seyfried, Meridith Glicksman. Neuropsychometric performance of asymptomatic HIV-infected subjects. AIDS. 1990. 4: 767-74.Year
1990
Journal
AIDS
Mycobacterial infection and HIV disease
Citation
W. Claiborne Dunagan. Mycobacterial infection and HIV disease. Missouri Medicine. 1990. 87: 79-81.Year
1990
Journal
Missouri Medicine
The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial
Citation
Frank S. Rhame, Henry H. Balfour, Margaret A. Fischl, Stephen A. Spector, Douglas D. Richman, Paul Volberding, Nellie I. Hansen, Carla Pettinelli, Ann C. Collier, James Anderson, John T. Carey, Michael F. Para, W. David Hardy, Raphael Dolin, William G. Powderly, J. Davis Allan, Brian Wong, Thomas C. Merigan, Vincent J. McAuliffe, Newton E. Hyslop. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. Annals of Internal Medicine. 1990. 112: 727-37.Year
1990
Journal
Annals of Internal Medicine
2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A phase I trial
Citation
John S. Lambert, Mindell Seidlin, Richard C. Reichman, Carol S. Plank, Maura Laverty, Gene D. Morse, Catherine Knupp, Colin McLaren, Carla Pettinelli, Fred T. Valentine, Raphael Dolin. 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A phase I trial. New England Journal of Medicine. 1990. 322: 1333-40.Year
1990
Journal
New England Journal of Medicine
Susceptibilities of zidovudine-susceptible and -resistant human immunodeficiency virus isolates to antiviral agents determined by using a quantitative plaque reduction assay
Citation
Brendan Larder, Bruce Chesebro, Douglas D. Richman. Susceptibilities of zidovudine-susceptible and -resistant human immunodeficiency virus isolates to antiviral agents determined by using a quantitative plaque reduction assay. Antimicrobial Agents and Chemotherapy. 1990. 34: 436-41.Year
1990
Journal
Antimicrobial Agents and Chemotherapy
Hematopoietic growth factors in the treatment of patients with HIV infection
Citation
Ronald T. Mitsuyasu. Hematopoietic growth factors in the treatment of patients with HIV infection. Biotherapy. 1990. 2: 173-81.Year
1990
Journal
Biotherapy